This list is an analysis based on recent market events. It's not an investment recommendation.
PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Sunrise, FL.
FAQs
What is PsyBio Therapeutics stock price today?▼
The current price of PSYBF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch PsyBio Therapeutics stock price performance more closely on the chart.
What is PsyBio Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange PsyBio Therapeutics stocks are traded under the ticker PSYBF.
Is PsyBio Therapeutics stock price growing?▼
PSYBF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year PsyBio Therapeutics has showed a -90% decrease.
What is PsyBio Therapeutics market cap?▼
Today PsyBio Therapeutics has the market capitalization of 808.98
What were PsyBio Therapeutics earnings last quarter?▼
PSYBF earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is PsyBio Therapeutics revenue for the last year?▼
PsyBio Therapeutics revenue for the last year amounts to 0 USD.
What is PsyBio Therapeutics net income for the last year?▼
PSYBF net income for the last year is -4.89M USD.
How many employees does PsyBio Therapeutics have?▼
As of November 2, 2026, the company has 118 employees.
In which sector is PsyBio Therapeutics located?▼
PsyBio Therapeutics operates in the Health & Wellness sector.
When did PsyBio Therapeutics complete a stock split?▼
PsyBio Therapeutics has not had any recent stock splits.
Where is PsyBio Therapeutics headquartered?▼
PsyBio Therapeutics is headquartered in Denver, Canada.